Program Information
Measurement and Monte Carlo Simulation of Stray Neutrons in Passive Scattering Proton Therapy: Needs and Challenges
J Farah1*, A Bonfrate1 , M Caresana2 , S Delacroix3 , L Donadille1 , N Dubourg1 , J Herault4 , V Lacoste1 , F Martinetti1 , C Nauraye3 , S Piau5 , R Sayah1 , F Trompier1 , I Vabre5 , I Clairand1 , (1) IRSN - Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-roses, ,(2) Politecnico di Milano, Milano, ,(3) Institut Curie - Centre de Protontherapie d Orsay, Orsay, ,(4) Centre Antoine Lacassagne, Nice, ,(5) Institut de Physique Nucleaire d Orsay, Orsay, ,
Presentations
SU-E-T-591 Sunday 3:00PM - 6:00PM Room: Exhibit HallPurpose:
Measure stray radiation inside a passive scattering proton therapy facility, compare values to Monte Carlo (MC) simulations and identify the actual needs and challenges.
Methods:
Measurements and MC simulations were considered to acknowledge neutron exposure associated with 75 MeV ocular or 180 MeV intracranial passively scattered proton treatments. First, using a specifically-designed high sensitivity Bonner Sphere system, neutron spectra were measured at different positions inside the treatment rooms. Next, measurement-based mapping of neutron ambient dose equivalent was fulfilled using several TEPCs and rem-meters. Finally, photon and neutron organ doses were measured using TLDs, RPLs and PADCs set inside anthropomorphic phantoms (Rando, 1 and 5-years-old CIRS). All measurements were also simulated with MCNPX to investigate the efficiency of MC models in predicting stray neutrons considering different nuclear cross sections and models.
Results:
Knowledge of the neutron fluence and energy distribution inside a proton therapy room is critical for stray radiation dosimetry. However, as spectrometry unfolding is initiated using a MC guess spectrum and suffers from algorithmic limits a 20% spectrometry uncertainty is expected. H*(10) mapping with TEPCs and rem-meters showed a good agreement between the detectors. Differences within measurement uncertainty (10-15%) were observed and are inherent to the energy, fluence and directional response of each detector. For a typical ocular and intracranial treatment respectively, neutron doses outside the clinical target volume of 0.4 and 11 mGy were measured inside the Rando phantom. Photon doses were 2-10 times lower depending on organs position. High uncertainties (40%) are inherent to TLDs and PADCs measurements due to the need for neutron spectra at detector position. Finally, stray neutrons prediction with MC simulations proved to be extremely dependent on proton beam energy and the used nuclear models and cross sections.
Conclusion:
This work highlights measurement and simulation limits for ion therapy radiation protection applications.
Contact Email: